Use of proton pump inhibitors and other acid-suppressing drugs was associated with a 30% increased risk of hospital-acquired pneumonia in a study by researcher Shoshana J. Herzig, MD, of Beth Israel Deaconess Medical Center and Harvard School of Medicine.

Herzig and colleagues estimate that 180,000 cases of hospital-acquired pneumonia and 33,000 deaths each year may be due to their use.